| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/24/2009 | US20090317452 Transdermal patch |
| 12/24/2009 | US20090317450 Pharmacokinetics of iontophoretic sumatriptan administration |
| 12/24/2009 | US20090317448 Tympanic membrane patch |
| 12/24/2009 | US20090317445 Drug delivery system with thermoswitchable membranes |
| 12/24/2009 | US20090317443 Coated implant |
| 12/24/2009 | US20090317442 Super Elastic Epoxy Hydrogel |
| 12/24/2009 | US20090317440 Anti-mitotic anti-proliferative compounds |
| 12/24/2009 | US20090317439 Cell Preparations for Extemporaneous Use, Useful for Healing and Rejuvenation In Vivo |
| 12/24/2009 | US20090317438 Whole blood-derived coagulum device for treating bone defects |
| 12/24/2009 | US20090317437 Cellulose gel formulations |
| 12/24/2009 | US20090317429 Aloe vera cotton swab tips |
| 12/24/2009 | US20090317355 Abuse resistant melt extruded formulation having reduced alcohol interaction |
| 12/24/2009 | US20090317338 Foamable iodine compositions |
| 12/24/2009 | US20090317337 Aerosol formulation for inhalation containing an anticholinergic agent |
| 12/24/2009 | US20090317336 Method and apparatus for high mass concentration nano particle generation |
| 12/24/2009 | US20090314290 Drug delivery in association with medical or surgical procedures |
| 12/23/2009 | WO2009155488A2 Novel oxalate salt and crystal of o-desmethylvenlafaxine |
| 12/23/2009 | WO2009155405A1 Medical devices employing conductive polymers for delivery of therapeutic agents |
| 12/23/2009 | WO2009155397A2 Edible holographic silk products |
| 12/23/2009 | WO2009155135A1 Composition comprising liposome-entrapped doxorubicin and methods of admnistration for treatment of multiple myeloma |
| 12/23/2009 | WO2009154978A2 Self-preserved emulsions |
| 12/23/2009 | WO2009154810A2 Delivery systems for multiple active agents |
| 12/23/2009 | WO2009154648A1 Polyamine enhanced formulations for triptan compound iontophoresis |
| 12/23/2009 | WO2009154396A2 Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release |
| 12/23/2009 | WO2009154169A1 Peptide derivative and composition for promoting tear secretion comprising the same |
| 12/23/2009 | WO2009154148A1 Analgesic anti-inflammatory preparation for external application |
| 12/23/2009 | WO2009154147A1 Oxybuprocaine-containing analgesic/antipruritic preparation for external application |
| 12/23/2009 | WO2009154086A1 Water-soluble acrylic acid salt polymer and gelling base |
| 12/23/2009 | WO2009153798A1 Cross-linked dextrin as a tablet disintegrant/excipient |
| 12/23/2009 | WO2009153704A1 Concentrated oxaliplatin solution and its method of preparation |
| 12/23/2009 | WO2009153654A1 Solid dosage forms of antiretrovirals |
| 12/23/2009 | WO2009153635A1 A chronotherapeutic pharmaceutical dosage form |
| 12/23/2009 | WO2009153634A1 A transmucosal delivery system |
| 12/23/2009 | WO2009153633A1 Pharmaceutical dosage form for the site-specific delivery of more than one active pharmaceutical ingredient |
| 12/23/2009 | WO2009153632A1 A gastroretentive pharmaceutical dosage form |
| 12/23/2009 | WO2009153448A1 Oral composition containing an anti-plaque agent of the thienopyridine family in the form of a base |
| 12/23/2009 | WO2009153346A2 Stabilization of amorphous drugs using sponge-like carrier matrices |
| 12/23/2009 | WO2009153305A2 Pharmaceutical compositions of montelukast sodium |
| 12/23/2009 | WO2009153200A1 Preparation containing glucosamine and/or chondroitin for prophylaxis and treatment of arthrosis and for supporting the immune system |
| 12/23/2009 | WO2009153039A1 Container for medical products and method for production of said container |
| 12/23/2009 | WO2009153019A1 Composition for transdermal delivery of cationic active agents |
| 12/23/2009 | WO2009152922A1 Directly injection moldable and rapidly disintegrating tablet matrix |
| 12/23/2009 | WO2009152921A1 Directly extrudable polyol combination |
| 12/23/2009 | WO2009152777A1 A stable and release-controlled rasagiline transdermal patch and method of preparation thereof |
| 12/23/2009 | WO2009152597A2 Topical use composition for combatting ectoparasites in dogs and cats |
| 12/23/2009 | WO2009136884A3 Metformin-pioglitazone formulation with antihyperglycemic effects |
| 12/23/2009 | WO2009136398A3 Stable benzimidazole formulation |
| 12/23/2009 | WO2009135178A3 Methods for production and use of substance-loaded erythrocytes (s-les) for observation and treatment of microvascular hemodynamics |
| 12/23/2009 | WO2009133100A3 Ordered mesoporous silica material |
| 12/23/2009 | WO2009131473A3 Composite carrier for powdery drugs, a method of the carrier manufacturing and a plant for manufacturing the composite carrier particles |
| 12/23/2009 | WO2009129519A3 Benzodiazepine formulation in a polyorthoester carrier |
| 12/23/2009 | WO2009129301A3 Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas |
| 12/23/2009 | WO2009121069A3 Compositions and methods for the preparation of nanoemulsions |
| 12/23/2009 | WO2009116077A3 Injectable preparation containing a pyridinol derivative |
| 12/23/2009 | WO2009109289A3 Mixture for producing rapidly disintegrating tablets |
| 12/23/2009 | WO2009100871A3 Drug delivery system with stabilising effect |
| 12/23/2009 | WO2009095799A3 Coded medications and methods for preparing same for identification and distinguishment |
| 12/23/2009 | WO2009095639A3 Freezable lubricant |
| 12/23/2009 | WO2009095562A3 Biomaterial for the controlled delivery of ingredients |
| 12/23/2009 | WO2009084041A4 Pharmaceutical compositions of dexibuprofen |
| 12/23/2009 | WO2009073193A3 Methods of synthesis and use of chemospheres |
| 12/23/2009 | WO2009068278A3 A pharmaceutical composition |
| 12/23/2009 | WO2009058913A3 Yeast cell wall protein (ycwp) encapsulated multilyered nanoparticles for nucleic acid delivery (sirna) |
| 12/23/2009 | WO2008108908A3 Cellulose acetate 1,2-benzenedicarboxylate cosmeceutical |
| 12/23/2009 | EP2135905A2 Patch and patch preparation |
| 12/23/2009 | EP2135612A1 Use of ATP in the preparation of a medicament for treating, alleviating and/or enhancing survival of pre-terminal cancer patients |
| 12/23/2009 | EP2135604A1 Infusion preparation for cancer patient |
| 12/23/2009 | EP2135602A1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 12/23/2009 | EP2135601A1 Stabilization of amorphous drugs using sponge-like carrier matrices |
| 12/23/2009 | EP2135600A1 Targeting agent for cancer cell or cancer-associated fibroblast |
| 12/23/2009 | EP2135512A1 Compound based on malic acid, caffeic acid, a flavan-3-ol and an anthocyane and its use in food and medicine |
| 12/23/2009 | EP2134740A2 Self-assembling nanoparticle drug delivery system |
| 12/23/2009 | EP2134457A1 Process for making crystals |
| 12/23/2009 | EP2134409A1 Implantable medicament delivery device and delivery tool and method for use therewith |
| 12/23/2009 | EP2134353A1 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery |
| 12/23/2009 | EP2134337A1 Novel burn treatment composition |
| 12/23/2009 | EP2134334A1 Nanoparticulated anesthetic composition for topic use |
| 12/23/2009 | EP2134329A1 Composition and microsphere for controlled-release of exendin, and method of preparing the same |
| 12/23/2009 | EP2134328A1 A gelatin capsule with extra cap for combined therapies |
| 12/23/2009 | EP2134327A1 Pharmaceutical compositions of poorly soluble drugs |
| 12/23/2009 | EP2134326A1 Pharmaceutical compositions comprising irbesartan |
| 12/23/2009 | EP2134325A2 Stable solid dosage forms of an antidepressant |
| 12/23/2009 | EP2134322A1 Intravesical apaziquone administration following transurethral resection for treating cancer |
| 12/23/2009 | EP2134321A2 Orally administrable films |
| 12/23/2009 | EP2134320A1 Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases |
| 12/23/2009 | EP2134295A1 Bio-artificial pancreas and a procedure for preparation of same |
| 12/23/2009 | EP1838295B1 Anthelmintic composition |
| 12/23/2009 | EP1776400B1 Temperature sensitive polymers |
| 12/23/2009 | EP1748760B1 Superloaded liposomes for drug delivery |
| 12/23/2009 | EP1628634B1 Novel lipid mixtures for synthetic surfactants |
| 12/23/2009 | EP1453484B1 Methods and materials for detecting genetic material |
| 12/23/2009 | EP1425295B1 Modified peptides and their use for the treatment of autoimmune diseases |
| 12/23/2009 | EP1420787B1 Ophthalmic composition comprising an ascomycin |
| 12/23/2009 | EP1356816B1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| 12/23/2009 | EP1341538B1 Medicament compositions with salts of tiotropium and epinastin for the therapy of respiratory diseases |
| 12/23/2009 | EP1310229B1 Method of manufacturing seamless capsule |
| 12/23/2009 | EP1107782B1 Oral vaccine compositions |
| 12/23/2009 | CN201366104Y Externally-applied gynecological suppository with active protein and nano-silver |
| 12/23/2009 | CN201366086Y Packaging machine capable of automatically producing shells for wax pills |
| 12/23/2009 | CN201366015Y Novel traditional Chinese medicine plaster |